UroGen Pharma Ltd.

UroGen Pharma Ltd. - Enterprise Valueverified

URGN

Price:

$40.45

Market Cap:

$1.97B

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; Mitomycin a generic drug used off-label as an adjuvant chemotherapy for the treatment of low-grade NMIBC after trans-urethral resection of bladder tumor; Zusduri, a sustained-release formulation of mitomycin for the treatment of non-muscle invasive bladder cancer (NMIBC); and Jelmyto for pyelocalyceal solutions. The company’s lead product candidates are UGN-103, which is in phase 3 of clinical trial for intravesical solution; and UGN-104 that ...[Read more]

Industry

Biotechnology

IPO Date

2017-05-04

Stock Exchange

NASDAQ

Ticker

URGN

The Enterprise Value as of July 2026 (TTM) for UroGen Pharma Ltd. (URGN) is 2.06B

According to UroGen Pharma Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.06B. This represents a change of 113.90% compared to the average of 961.47M of the last 4 quarters.

UroGen Pharma Ltd. (URGN) Historical Enterprise Value (quarterly & annually)

How has URGN Enterprise Value performed in the past?

The mean historical Enterprise Value of UroGen Pharma Ltd. over the last ten years is 444.46M. The current 2.06B Enterprise Value has changed 46.17% with respect to the historical average. Over the past ten years (40 quarters), URGN's Enterprise Value was at its highest in in the December 2025 quarter at 1.17B. The Enterprise Value was at its lowest in in the June 2017 quarter at 89.14M.

Quarterly (TTM)
Annual

Average

444.46M

Median

374.58M

Minimum

146.01M

Maximum

1.14B

UroGen Pharma Ltd. (URGN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of UroGen Pharma Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 926.88%

Maximum Annual Enterprise Value = 1.14B

Minimum Annual Increase = -50.59%

Minimum Annual Enterprise Value = 146.01M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20251.14B180.48%
2024408.04M-6.61%
2023436.91M77.60%
2022246.01M45.95%
2021168.56M-50.59%
2020341.12M-46.53%
2019637.96M10.55%
2018577.06M70.50%
2017338.46M131.80%
2016146.01M926.88%

UroGen Pharma Ltd. (URGN) Average Enterprise Value

How has URGN Enterprise Value performed in the past?

The current Enterprise Value of UroGen Pharma Ltd. (URGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

663.14M

5-year avg

480.80M

10-year avg

444.46M

UroGen Pharma Ltd. (URGN) Enterprise Value vs. Peers

How is URGN’s Enterprise Value compared to its peers?

UroGen Pharma Ltd.’s Enterprise Value is less than Kodiak Sciences Inc. (2.49B), less than Mind Medicine (MindMed) Inc. (4.34B), greater than Xencor, Inc. (1.61B), less than Tango Therapeutics, Inc. (3.09B), less than Nurix Therapeutics, Inc. (2.44B), greater than Oculis Holding AG (443.01M), greater than BridgeBio Oncology Therapeutics Inc. (609.67M), less than AnaptysBio, Inc. (2.28B), greater than Phathom Pharmaceuticals, Inc. (913.76M), greater than ProKidney Corp. (1.08B),

Build a custom stock screener for UroGen Pharma Ltd. (URGN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like UroGen Pharma Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

UroGen Pharma Ltd. (URGN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like UroGen Pharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is UroGen Pharma Ltd.'s Enterprise Value?

What is the highest Enterprise Value for UroGen Pharma Ltd. (URGN)?

What is the 3-year average Enterprise Value for UroGen Pharma Ltd. (URGN)?

What is the 5-year average Enterprise Value for UroGen Pharma Ltd. (URGN)?

How does the current Enterprise Value for UroGen Pharma Ltd. (URGN) compare to its historical average?